Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated ...

Carlyle Group (CG) is reportedly set to sell up to a 10% stake in Indian drugmaker Piramal Pharma, in a deal that could fetch ...

Private equity firm Carlyle Group is preparing to offload up to a 10% stake in India's Piramal Pharma , online news portal ...

The acquisition is being done by Alembic Pharmaceuticals, Inc, the company's US subsidiary, Alembic said in a statement.

Why did two private equity firms with more than $460 billion under management want a little old gene therapy biotech called ...

New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to speed up the process.

Protagonist is directly going up against Eli Lilly, which is advancing retatrutide, also a triple-G agonist, in a Phase II ...

"Piramal Pharma announces $90m investment to expand US sites" was originally created and published by Pharmaceutical ...

Piramal Pharma recently broke ground on the expansion plan for its Lexington, Kentucky facility. To celebrate this important milestone and the future growth it signifies for the company, Piramal ...

Pil Italica Lifestyle Ltd. (NSE: PILITA) is down 1.84% from its previous close price Rs. 16.31. The last updated share price is Rs. 16.01 as of 2025-06-20 15:52:00. Market capitalization of the stock ...

Cycle Pharmaceuticals announced that the FDA has approved HARLIKU (nitisinone) Tablets for the reduction of urine homogentisic acid (HGA) in adult patients w ...

NEW DELHI and MUMBAI, India, June 19, 2025 /PRNewswire/ — The Bombay High Court dismissed a Public Interest Litigation (PIL) challenging the professional indemnity and risk–management services ...